|
|
|
Insider
Information: |
Lamattina John L |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
512,782 |
|
Indirect Shares
|
59,053 |
|
|
Direct
Value |
$14,403,693 |
|
|
Indirect Value
|
$1,499,946 |
|
|
Total
Shares |
571,835 |
|
|
Total
Value |
$15,903,639 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-56.8%
|
-36.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pfizer Inc |
PFE |
Senior Vice President |
2007-06-29 |
383,190 |
2007-06-29 |
59,053 |
Premium* |
|
Thermo Fisher Scientific |
TMO |
Director |
2004-03-09 |
3,000 |
2004-03-09 |
0 |
Premium* |
|
Human Genome Sciences Inc |
HGSI |
Director |
2012-07-30 |
0 |
2008-11-12 |
0 |
Premium* |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2023-06-09 |
28,263 |
2011-02-07 |
0 |
Premium* |
|
Larimar Therapeutics Inc |
LRMR |
Director |
2019-01-24 |
31,376 |
2017-02-13 |
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-01-15 |
66,953 |
2020-10-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,142 |
28,263 |
0 |
- |
|
IMNM |
Immunome Inc. |
Director |
|
2023-01-15 |
4 |
A |
$4.00 |
$60,500 |
D/D |
15,125 |
66,953 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2022-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,004 |
26,402 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2021-11-16 |
4 |
S |
$161.86 |
$782,579 |
D/D |
(4,835) |
25,398 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2021-11-16 |
4 |
OE |
$32.30 |
$156,171 |
D/D |
4,835 |
30,233 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2021-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
630 |
25,398 |
0 |
- |
|
IMNM |
Immunome Inc. |
Director |
|
2021-05-24 |
4 |
B |
$18.44 |
$101,028 |
D/D |
5,440 |
51,828 |
2.39 |
% |
|
IMNM |
Immunome Inc. |
Director |
|
2020-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
46,388 |
46,388 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
831 |
24,768 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2019-08-01 |
4 |
OE |
$32.30 |
$80,750 |
D/D |
2,500 |
24,784 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2019-08-01 |
4 |
D |
$95.58 |
$80,958 |
D/D |
(847) |
23,937 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
835 |
22,284 |
0 |
- |
|
LRMR |
Larimar Therapeutics Inc |
Director |
|
2019-01-24 |
4 |
A |
$4.38 |
$47,497 |
D/D |
10,844 |
31,376 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2018-09-04 |
4 |
AS |
$254.96 |
$850,292 |
D/D |
(3,335) |
21,449 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2018-09-04 |
4 |
OE |
$12.53 |
$41,788 |
D/D |
3,335 |
24,784 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
21,449 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2018-06-04 |
4 |
AS |
$194.51 |
$778,039 |
D/D |
(4,000) |
20,956 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2018-06-04 |
4 |
OE |
$12.53 |
$50,120 |
D/D |
4,000 |
24,956 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2018-03-05 |
4 |
OE |
$10.12 |
$33,750 |
D/D |
3,335 |
24,291 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2018-03-05 |
4 |
AS |
$160.90 |
$536,604 |
D/D |
(3,335) |
20,956 |
0 |
- |
|
LRMR |
Larimar Therapeutics Inc |
Director |
|
2018-01-03 |
4 |
A |
$5.18 |
$47,495 |
D/D |
9,169 |
20,532 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2017-11-17 |
4 |
S |
$139.79 |
$559,160 |
D/D |
(4,000) |
20,956 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2017-11-17 |
4 |
OE |
$10.12 |
$40,480 |
D/D |
4,000 |
24,956 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
666 |
20,956 |
0 |
- |
|
LRMR |
Larimar Therapeutics Inc |
Director |
|
2017-02-13 |
4 |
A |
$4.18 |
$47,497 |
D/D |
11,363 |
11,363 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|